Melanogenesis is the biological process responsible for melanin production in the skin, primarily within melanocytes located in the epidermis. This process synthesizes two types of melanin: eumelanin (brown–black) and pheomelanin (yellow–red), which protect the skin from harmful UV radiation. Melanogenesis is regulated by both intrinsic factors (e.g., hormones, cytokines) and extrinsic factors (e.g., UV radiation). Key signaling pathways involved include cAMP, p53, ERK/MAPK, and PI3K/Akt. Enzymes like tyrosinase and tyrosinase-related proteins (TYRP-1, TYRP-2) are central to melanin synthesis, converting L-tyrosine into melanin. Transcription factors such as MITF regulate the expression of these enzymes. UV exposure induces DNA damage, leading to the release of α-MSH, which binds to MC1R on melanocytes, activating melanogenesis. Dysregulation of this process can result in pigmentation disorders like melasma or contribute to skin cancer development. Understanding these pathways is crucial for developing treatments for pigmentation disorders and improving therapies for conditions like vitiligo or hyperpigmentation.